Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO

H Trimarchi, FC Fervenza, R Coppo - Journal of Nephrology, 2024 - Springer
IgA nephropathy is the most common primary glomerulonephritis worldwide, and an
important cause of kidney failure, as 20–40% of patients progress to renal replacement …

Histologic and clinical Factors associated with kidney outcomes in IgA vasculitis nephritis

SJ Barbour, R Coppo, L Er, E Pillebout… - Clinical Journal of the …, 2024 - journals.lww.com
Background Nephritis is a common manifestation of IgA vasculitis and is morphologically
indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney …

Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors

L Gadola, MJ Cabrera, M Garau, R Coitiño… - Renal …, 2023 - Taylor & Francis
Abstract Aim IgA nephropathy (IgAN), the most common glomerulopathy worldwide and in
Uruguay, raised treatment controversies. The study aimed to analyze long-term IgAN …

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation

D Di, L Liu, Y Wang, Y Yang, S Jiang, W Li - Renal Failure, 2023 - Taylor & Francis
Purpose Whether different crescentic proportions determine the progression of IgA
nephropathy (IgAN) with crescents in less than 50% of glomeruli remains controversial. We …

A novel clinical− radiomic nomogram for the crescent status in IgA nephropathy

X Qin, L Xia, X Hu, W Xiao, X Huaming… - Frontiers in …, 2023 - frontiersin.org
Objective We used machine-learning (ML) models based on ultrasound radiomics to
construct a nomogram for noninvasive evaluation of the crescent status in immunoglobulin A …

New insights into the pathogenesis and therapies of IgA nephropathy

H Suzuki, J Novak - Journal of Clinical Medicine, 2022 - mdpi.com
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide
[1]. Up to 40% of IgAN patients progress to kidney failure within 20 years following diagnosis …

[HTML][HTML] Evaluating Progression Risk in Patients with IgAN

DC Cattran, J Floege, R Coppo - Kidney International Reports, 2023 - Elsevier
The highly variable rate of decline in kidney function in patients with immunoglobulin A
nephropathy (IgAN) provides a major clinical challenge. Predicting which patients will …

Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1

X Bi, Y Yu, S Zhou, Y Zhou, J Zhao, J Xiong - Nephron, 2024 - karger.com
Background The renoprotective benefits of adding immunosuppressant therapy to
corticosteroid (CS) treatment for immunoglobulin A nephropathy (IgAN) patients with less …

Long-term follow-up of IgA nephropathy: clinicopathological features and predictors of outcomes

YL Haaskjold, NG Lura, R Bjørneklett… - Clinical Kidney …, 2023 - academic.oup.com
Background The establishment of the Oxford classification and newly developed prediction
models have improved the prognostic information for immunoglobulin A nephropathy (IgAN) …

The Effects of Perilla frutescens Extracts on IgA Nephropathy: A Systematic Review and Meta-Analysis

G Adam, AM Adam, S Robu, V Harabor, A Harabor… - Pharmaceuticals, 2023 - mdpi.com
(1) Background: Chronic renal disorders (CRD) are associated with significant comorbidities
and necessitate complex therapeutic management. As time passed, Perilla frutescens (PF) …